Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Urogen Pharma Ltd.

Clinical trials sponsored by Urogen Pharma Ltd., explained in plain language.

UroGen Pharma Ltd. URGN NASDAQ

Develops therapies for urological cancers and diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New cancer gel shows promise for rare urinary tract tumors

Disease control Recruiting now

This study tests a new gel-like drug, UGN-104, placed directly into the upper urinary tract to treat low-grade cancer. About 70 adults with small tumors will receive the treatment to see if it can completely eliminate visible cancer. The goal is to control the disease and avoid m…

Phase: PHASE3 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC